Search

Evgenii Rubalskii (Hannover Medical School) and colleagues published a new paper in Antibiotics presenting their findings on using phage therapy to treat critical infections related to cardiothoracic surgery. They showed that phages (in com

Check out these two new phage-related podcast episodes: Dr. Steffanie Strathdee, Co-Director of the Center for Innovative Phage Applications and Therapeutics (IPATH) discusses AMR on "This Podcast Will Kill You", and "The Bio Report" talks

A new phage therapy book edited by Aidan Coffey (Cork Institute of Technology, Ireland) and Colin Buttimer (University College Cork, Ireland) has been published by Caister Academic Press. The book is entitled "Bacterial Viruses: Exploitatio

Vitalis Phage Therapy Tune in at 11 a.m. IST this Sunday, 24th May for a live discussion with Dr. Gopal Nath, who will talk to us about his experiences with clinical application of phage therapy, presenting phage therapy to medical regulato

Ortal Yerushalmy (Hebrew University of Jerusalem) and colleagues published a new paper in Antibiotics describing their newly-created Israeli Phage Bank (IPB). Read about their collection of around 300 phages matching around 21 bacterial spe

Check out this fantastic spotlight of the people and goals behind BCM TAILΦR Labs, a recently-established phage therapy service center at Baylor College of Medicine in Houston, Texas. Founders Anthony Maresso, Austen Terwilliger and Sabrina

A new phage therapy book edited by Aidan Coffey (Cork Institute of Technology, Ireland) and Colin Buttimer (University College Cork, Ireland) has been published by Caister Academic Press. The book is entitled "Bacterial Viruses: Exploitatio

It's been 2 years since Isabelle Carnell-Holdaway, a teenager in the UK with cystic fibrosis, was treated by the Hatfull Lab's Mycobacterium abscessus phages. Here's an update on how she's doing now!

EIT Health Catapult in Germany is having a pitch competition for its regional BioTech category finalists, and one of them is PhagoMed, a phage therapy company out of Austria. Tune in May 26 to watch the pitch!

EIT Health Catapult in Germany is having a pitch competition for its regional BioTech category finalists, and one of them is PhagoMed, a phage therapy company out of Austria. Tune in May 26 to watch the pitch!

It's been 2 years since Isabelle Carnell-Holdaway, a teenager in the UK with cystic fibrosis, was treated by the Hatfull Lab's Mycobacterium abscessus phages. Here's an update on how she's doing now!

Ortal Yerushalmy (Hebrew University of Jerusalem) and colleagues published a new paper in Antibiotics describing their newly-created Israeli Phage Bank (IPB). Read about their collection of around 300 phages matching around 21 bacterial spe

Check out this fantastic spotlight of the people and goals behind BCM TAILΦR Labs, a recently-established phage therapy service center at Baylor College of Medicine in Houston, Texas. Founders Anthony Maresso, Austen Terwilliger and Sabrina

Vitalis Phage Therapy Tune in at 11 a.m. IST this Sunday, 24th May for a live discussion with Dr. Gopal Nath, who will talk to us about his experiences with clinical application of phage therapy, presenting phage therapy to medical regulato

James Doub (University of Maryland School of Medicine) and colleagues published their successful eradication of a 72-year-old man's prosthetic joint infection with phage therapy, which was done alongside Adaptive Phage Therapeutics and the

James Doub (University of Maryland School of Medicine) and colleagues published their successful eradication of a 72-year-old man's prosthetic joint infection with phage therapy, which was done alongside Adaptive Phage Therapeutics and the

Armata Pharmaceuticals, a Los Angeles-based phage therapy company, has several openings in R&D, process development, DNA sequencing, genetic engineering, project management, quality assurance and quality control.

Armata Pharmaceuticals, a Los Angeles-based phage therapy company, has several openings in R&D, process development, DNA sequencing, genetic engineering, project management, quality assurance and quality control.

Vitalis Phage Therapy In these difficult times of pandemic lockdowns and quarantine, we bring you a series of discussions called "All About Phage Therapy". For the first discussion, senior microbiologist Prof. Sanjay Chhibber from Panjab Un

US biotech company Intralytix was just awarded a multimillion dollar grant from NIAID to perform a phase 1/2a clinicial trial to assess safety and efficacy of phage therapy against Shigella.